Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Full Text
Peer Reviewed
See detailThe European Large Area ISO Survey - VI. Discovery of a new hyperluminous infrared galaxy
Morel, Thierry ULg; Efstathiou, A.; Serjeant, S. et al

in Monthly Notices of the Royal Astronomical Society (2001), 327

We report the discovery of the first hyperluminous infrared galaxy (HyLIG) in the course of the European Large Area ISO Survey (ELAIS). This object has been detected by ISO at 6.7, 15 and 90μm, and is ... [more ▼]

We report the discovery of the first hyperluminous infrared galaxy (HyLIG) in the course of the European Large Area ISO Survey (ELAIS). This object has been detected by ISO at 6.7, 15 and 90μm, and is found to be a broad-line, radio-quiet quasar at a redshift [formmu4]z=1.099. From a detailed multicomponent model fit of the spectral energy distribution, we derive a total IR luminosity L[SUB]IR[/SUB] [formmu5](1-1000μm)~1.0à 10[SUP]13[/SUP]h65-2L[SUB]solar[/SUB] [formmu6](q[SUB]0[/SUB]=0.5), and discuss the possible existence of a starburst contributing to the far-IR output. Observations to date present no evidence for lens magnification. This galaxy is one of the very few HyLIGs with a X-ray detection. On the basis of its soft X-ray properties, we suggest that this broad-line object may be the face-on analogue of narrow-line, Seyfert-like HyLIGs. [less ▲]

Detailed reference viewed: 13 (1 ULg)
Full Text
Peer Reviewed
See detailThe European Large Area ISO Survey - VIII. 90-microns final analysis and source counts
Heraudeau, P.; Oliver, S.; del Burgo, C. et al

in Monthly Notices of the Royal Astronomical Society (2004), 354

We present a re-analysis of the European Large Area Infrared Space Observatory (ISO) Survey (ELAIS) 90-μm observations carried out with ISOPHOT, an instrument on board the ISO of the European Space ... [more ▼]

We present a re-analysis of the European Large Area Infrared Space Observatory (ISO) Survey (ELAIS) 90-μm observations carried out with ISOPHOT, an instrument on board the ISO of the European Space Agency. With more than 12 deg[SUP]2[/SUP], the ELAIS survey is the largest area covered by ISO in a single programme and is about one order of magnitude deeper than the IRAS 100-μm survey. The data analysis is presented and was mainly performed with the PHOT interactive analysis software but using the pairwise method of Stickel et al. for signal processing from edited raw data to signal per chopper plateau. The ELAIS 90-μm catalogue contains 237 reliable sources with fluxes larger than 70 mJy and is available in the electronic version of this article. Number counts are presented and show an excess above the no-evolution model prediction. This confirms the strong evolution detected at shorter (15 μm) and longer (170 μm) wavelengths in other ISO surveys. The ELAIS counts are in agreement with previous works at 90 μm and in particular with the deeper counts extracted from the Lockman hole observations. Comparison with recent evolutionary models show that the models of Franceschini et al. and Guiderdoni et al. (which includes a heavily extinguished population of galaxies) give the best fit to the data. Deeper observations are nevertheless required to discriminate better between the model predictions in the far-infrared, and are scheduled with the Spitzer Space Telescope, which has already started operating, and will also be performed by ASTRO-F. [less ▲]

Detailed reference viewed: 11 (1 ULg)
Full Text
Peer Reviewed
See detailThe European Large-Area ISO Survey (ELAIS): the final band-merged catalogue
Rowan-Robinson, M.; Lari, C.; Perez-Fournon, I. et al

in Monthly Notices of the Royal Astronomical Society (2004), 351

We present the final band-merged European Large-Area ISO Survey (ELAIS) Catalogue at 6.7, 15, 90 and 175 μm, and the associated data at U, g', r', i', Z, J, H, K and 20 cm. The origin of the survey ... [more ▼]

We present the final band-merged European Large-Area ISO Survey (ELAIS) Catalogue at 6.7, 15, 90 and 175 μm, and the associated data at U, g', r', i', Z, J, H, K and 20 cm. The origin of the survey, infrared and radio observations, data-reduction and optical identifications are briefly reviewed, and a summary of the area covered and the completeness limit for each infrared band is given. A detailed discussion of the band-merging and optical association strategy is given. The total Catalogue consists of 3762 sources. 23 per cent of the 15-μm sources and 75 per cent of the 6.7-μm sources are stars. For extragalactic sources observed in three or more infrared bands, colour-colour diagrams are presented and discussed in terms of the contributing infrared populations. Spectral energy distributions (SEDs) are shown for selected sources and compared with cirrus, M82 and Arp220 starburst, and active galactic nuclei (AGN) dust torus models. Spectroscopic redshifts are tabulated, where available. For the N1 and N2 areas, the Isaac Newton Telescope ugriz Wide Field Survey permits photometric redshifts to be estimated for galaxies and quasars. These agree well with the spectroscopic redshifts, within the uncertainty of the photometric method [~10 per cent in (1 +z) for galaxies]. The redshift distribution is given for selected ELAIS bands and colour-redshift diagrams are discussed. There is a high proportion of ultraluminous infrared galaxies (log[SUB]10[/SUB] of 1-1000 μm luminosity L[SUB]ir[/SUB] > 12.22) in the ELAIS Catalogue (14 per cent of 15-μm galaxies with known z), many with Arp220-like SEDs. 10 per cent of the 15-μm sources are genuine optically blank fields to r'= 24: these must have very high infrared-to-optical ratios and probably have z > 0.6, so are high-luminosity dusty starbursts or Type 2 AGN. Nine hyperluminous infrared galaxies (L[SUB]ir[/SUB] > 13.22) and nine extremely red objects (EROs) (r-K > 6) are found in the survey. The latter are interpreted as ultraluminous dusty infrared galaxies at z~ 1. The large numbers of ultraluminous galaxies imply very strong evolution in the star formation rate between z= 0 and 1. There is also a surprisingly large population of luminous (L[SUB]ir[/SUB] > 11.5), cool (cirrus-type SEDs) galaxies, with L[SUB]ir[/SUB]-L[SUB]opt[/SUB] > 0, implying A[SUB]V[/SUB] > 1. [less ▲]

Detailed reference viewed: 21 (4 ULg)
See detailEuropean legislation on methods for antibiotics detection in milk
Scippo, Marie-Louise ULg

Conference (2008, September 22)

Detailed reference viewed: 28 (1 ULg)
Full Text
See detailEuropean market trend for fishery and European regulations for imported fishery
Duquesne, Brigitte ULg

in Development orientations of shrimp production chain in Bac Lieu Province, July 1-2, 2008 : actes du colloque (2008)

Detailed reference viewed: 15 (5 ULg)
Full Text
See detailEuropean military higher education: War-Integrated Learning
Paile, Sylvain ULg

Conference (2009, December)

Detailed reference viewed: 13 (0 ULg)
See detailThe European Modules on Migrant Integration: a Source of Inspiration for the Member States?
Martiniello, Marco ULg

Scientific conference (2011, October 23)

Detailed reference viewed: 32 (8 ULg)
Peer Reviewed
See detailEuropean multicentre evaluation of the Super Aution SA-4220 urinalysis analyser
Galimany, R.; Arambarri, M.; Biosca et al

in Clinical Chemistry & Laboratory Medicine (1998), 36(12), 947-58

A multicentre evaluation of the urine test strip analyser Super Aution-4220 was carried out in six laboratories. The analytical performance of the instrument with regard to imprecision, linearity ... [more ▼]

A multicentre evaluation of the urine test strip analyser Super Aution-4220 was carried out in six laboratories. The analytical performance of the instrument with regard to imprecision, linearity, detection limit, drift, carry-over and method comparison was studied. Using the Aution stick 8 test strip the pH, glucose, protein, ketones, bilirubin, blood, urobilinogen and leukocyte esterase were analysed. Specific gravity measurements were performed by refractive index method. Within-run and between-run imprecision determined at three levels of analyte were good. No carry-over was observed. Obtained results were linear through all the described analytical range. No significant drift was detected. Method comparison with some quantitative methods was performed and showed a good correlation with most of the analytes. The study of interferences showed minor interferences by common therapeutic drugs with the measurement of some analytes. During the assessment period of about 6 months no breakdown occurred in any laboratory. The Super Aution urine analyser appeared to be a highly automated analyser of urinary test strips. The operation was simple and the maintenance required only a few minutes a day. [less ▲]

Detailed reference viewed: 21 (0 ULg)
Full Text
Peer Reviewed
See detailEuropean multicentre validation study of the accuracy of E/e' ratio in estimating invasive left ventricular filling pressure: EURO-FILLING study.
Galderisi, Maurizio; Lancellotti, Patrizio ULg; Donal, Erwan et al

in European Heart Journal - Cardiovascular Imaging (2014)

AIMS: The non-invasive estimation of left ventricular filling pressures (LVFPs) represents a main goal in the clinical setting. Current recommendations encourage the use of pulsed-wave Tissue Doppler for ... [more ▼]

AIMS: The non-invasive estimation of left ventricular filling pressures (LVFPs) represents a main goal in the clinical setting. Current recommendations encourage the use of pulsed-wave Tissue Doppler for calculating the ratio between the preload-dependent transmitral E velocity and the average of septal and lateral early diastolic velocities (e') of the mitral annulus. Despite its wide use, real utility of the E/e' ratio has been recently challenged in patients with either very advanced heart failure or preserved left ventricular (LV) ejection fraction. However, only few studies performed the invasive and non-invasive estimation of LVFP simultaneously. The EURO-FILLING Study will validate the E/e' ratio (and additional non-invasive estimates) against simultaneously measured LVFP obtained by left heart catheterization in a multicentre study involving reference European echo laboratories collecting a wide population sample size of cardiac patients with and without heart failure. METHODS AND RESULTS: The EURO-FILLING study is a large, prospective observational study in which simultaneous assessment of invasive and non-invasive measurements of LVFP will be acquired in eight reference European centres. Centralized reading of the collected parameters will be performed in a core laboratory. Not only standardized echo Doppler measurements but also novel echo parameters such as LV global longitudinal strain and global atrial strain (obtainable by two-dimensional speckle tracking echocardiography) will be tested for predicting invasive measurements of LVFP. CONCLUSIONS: The EURO-FILLING study is expected to provide important information on non-invasive assessment of LVFP and to contribute to the standardization of this assessment in clinical practice. [less ▲]

Detailed reference viewed: 12 (3 ULg)
Full Text
See detailThe European Multilingual Space. What are Consequences for Language Teaching?
Lucchini, Silvia ULg

in Makowich, G. V. (Ed.) The Common European Space of Education, Science, Culture (2005)

Detailed reference viewed: 4 (0 ULg)
Full Text
Peer Reviewed
See detailEuropean National Society Cardiovascular Journals. Background, rationale and mission statement of the "Editors' Club" (Task Force of the European Society of Cardiology).
Alfonso, Fernando; Ambrosio, Giuseppe; Pinto, Fausto J. et al

in Acta Cardiologica (2008), 63(3), 281-7

Detailed reference viewed: 10 (0 ULg)
Full Text
See detailEuropean Nonproliferation Policy 1993-1995 - Chapitre consacré à la Belgique
Michel, Quentin ULg

in Müller, Harald (Ed.) European Nonproliferation Policy 1993-1995 (1996)

Detailed reference viewed: 3 (0 ULg)
Full Text
Peer Reviewed
See detailEuropean Organization for Research and Treatment of Cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer
Ardizzoni, A.; Manegold, C.; Debruyne, C. et al

in Clinical Cancer Research : An Official Journal of the American Association for Cancer Research (2003), 9(1), 143-150

Purpose: The purpose of this study was to assess the activity and toxicity of a combined regimen of topotecan and cisplatin in "sensitive" (s) and "refractory" (r) small-cell lung cancer (SCLC) patients ... [more ▼]

Purpose: The purpose of this study was to assess the activity and toxicity of a combined regimen of topotecan and cisplatin in "sensitive" (s) and "refractory" (r) small-cell lung cancer (SCLC) patients treated previously. Experimental Design: Patients with measurable SCLC and progressive disease after one first-line regimen were eligible for the study. Patients were enrolled in two separate groups: r group (patients who failed first-line treatment <3 months from treatment discontinuation) and s group (patients who responded to first-line treatment and progressed 2:3 months after treatment discontinuation). Cisplatin was given i.v. at the dose of 60 mg/m(2) on day 1, and topotecan was administered as a daily i.v. infusion at the dose of 0.75 mg/m(2) from day 1 to 5, every 3 weeks. Results: A total of 110 eligible (68 s and 42 r) patients were enrolled from 24 institutions. The main patient characteristics were as follows: median age 60 (s) and 55 (r) years, median performance status 1 for both (s) and (r). Seventy-four percent (s) and 67% (r) had extensive stage disease, including 22% and 36%, respectively, with brain metastases. A total of 398 chemotherapy courses were administered [median 4 (s) and 3 (r) per patient]. The most frequent and serious toxicity was myelosuppression. Grade IV neutropenia occurred in 62% (s) and 49% (r) of patients, with a 19% (s) and 15% (r) incidence of febrile neutropenia, and grade IV thrombocytopenia in 54% (s) and 44% (r). Most of these toxicities occurred during the first chemotherapy course and led to topotecan dose reduction and/or delay in the following courses. Grade III-IV nonhematological toxicity was uncommon. Five deaths possibly related to toxicity occurred among s patients only. Objective responses have been documented in 20 s patients, 19 partial responses and 1 complete response, (29.4% response rate; 95% confidence interval, 19-42), whereas, among r patients, 10 partial responses have been observed (23.8% response rate; 95% confidence interval, 12-39). Median survival for s and r was 6.4 and 6.1 months, respectively. Conclusions: The combination of cisplatin and topotecan, at this dose and schedule, shows activity and promising results in patients with refractory SCLC, with reversible myelosuppression being the main side effect. Additional development of this regimen, using better-tolerated schedules, is warranted in patients with refractory SCLC. [less ▲]

Detailed reference viewed: 22 (5 ULg)
Full Text
Peer Reviewed
See detailEuropean outbreak of atypical myopathy in the autumn 2009.
Van Galen, Gaby ULg; Amory, Hélène ULg; Busschers, Evita et al

in Journal of Veterinary Emergency & Critical Care (2010)

Background: Atypical myopathy (AM) is an acute, severe rhabdomyolysis occurring in grazing horses. Since In the beginning of October 2009, a new outbreak affects started in several European countries ... [more ▼]

Background: Atypical myopathy (AM) is an acute, severe rhabdomyolysis occurring in grazing horses. Since In the beginning of October 2009, a new outbreak affects started in several European countries. Geographic, demographic and clinical data of the reported cases in the month October 2009 are described. Key Findings: The survival rate over the month October 2009 was 25%. The most frequently observed clinical signs were congestedive mucous membranes, dyspnea, tachycardia, depression, weakness, stiffness, recumbency, trembling, transpirationsweating, and myoglobinuria. Non-survivors were significantly more often likely to be recumbent than survivors. Prognostic factors, symptomatic treatment and preventive measures are discussed. Significance: Slight differences were encountered during the described outbreak of AM in October 2009 compared to previous studies. Equine practitioners should be alert aware that previous epidemiological studies have shown that after a high prevalence this autumn, for new cases are likely to occur in the upcoming spring 2010. [less ▲]

Detailed reference viewed: 114 (16 ULg)
Full Text
Peer Reviewed
See detailEuropean outbreaks of atypical myopathy in grazing horses (2006-2009): Determination of indicators for risk and prognostic factors
Van Galen, Gaby ULg; Saegerman, Claude ULg; Marcilllaud Pitel, Christel et al

in Equine Veterinary Journal (2012), DOI: 10.1111/j.2042-3306.2012.00555.x

Appropriate management of atypical myopathy (AM) requires the establishment of an accurate diagnosis and prognosis. Furthermore, preventive measures to avoid AM need to be refined. The aims of the study ... [more ▼]

Appropriate management of atypical myopathy (AM) requires the establishment of an accurate diagnosis and prognosis. Furthermore, preventive measures to avoid AM need to be refined. The aims of the study were as follows: 1) to improve the diagnosis of AM; 2) to identify prognostic predictors; and 3) to refine recommended preventive measures based on indicators of risk factors. [less ▲]

Detailed reference viewed: 217 (18 ULg)
Full Text
Peer Reviewed
See detailThe European partnership with MERCOSUR: a Relationship based on Strategic and Neo-liberal principles
Santander, Sébastian ULg

in Journal of European Integration (2005), 27, 3

Since the early 1990s, the European Union has developed new instruments to consolidate its external action, especially in ‘low politics’. These new instruments include the signing of interregional ... [more ▼]

Since the early 1990s, the European Union has developed new instruments to consolidate its external action, especially in ‘low politics’. These new instruments include the signing of interregional arrangements with other regional groups. The EU’s region–to–region strategy towards the Common Market of the South (Mercosur) is in keeping with the latest trends of interregionalism. Since the birth of Mercosur, the EU has given technical, financial and diplomatic support to South America’s new regional- ism. The long–term goal is to conclude a region–to–region agreement in the political, cooperation and trade fields. By providing this support, the EU plays a role as an ‘exter- nal federator’ for new regional experiences through its interregionalist projects. Although ‘new interregionalism’ is a corollary of the new regionalism, interregionalism can contribute to the consolidation of regionalism. Moreover, by encouraging economic multilateralism, interregional arrangements can improve the governance of globalisation. [less ▲]

Detailed reference viewed: 99 (6 ULg)
Full Text
Peer Reviewed
See detailThe European Partnership with MERCOSUR: a Relationship Based on Strategic and Neoliberal Principles
Santander, Sébastian ULg

in Söderbaum, Frederik; Van Langenhove, Luk (Eds.) The EU as a Global Player: The Politics of Interregionalism (2006)

This article deals with the European Union’s Latin-American strategy and especially the relations that the European regional space has developed with the MERCOSUR since the early 1990s. The goal of the EU ... [more ▼]

This article deals with the European Union’s Latin-American strategy and especially the relations that the European regional space has developed with the MERCOSUR since the early 1990s. The goal of the EU is to conclude a bloc to bloc Association Agreement with the MERCOSUR which would cover both the political and cooperation aspects and which would include an ambitious free trade area for goods, services and investment. [less ▲]

Detailed reference viewed: 87 (7 ULg)
Full Text
Peer Reviewed
See detailA European patient record study on diagnosis and treatment of chemotherapy-induced anaemia
Ludwig, H.; Aapro, M.; Bokemeyer, C. et al

in Supportive Care in Cancer (2014), 22

Purpose – Patients with cancer frequently experience chemotherapy‐induced anaemia (CIA) and iron deficiency (ID). Erythropoiesis‐stimulating agents (ESA), iron supplementation and blood transfusions are ... [more ▼]

Purpose – Patients with cancer frequently experience chemotherapy‐induced anaemia (CIA) and iron deficiency (ID). Erythropoiesis‐stimulating agents (ESA), iron supplementation and blood transfusions are available therapies. This study evaluated routine practice in CIA management. Methods – Medical oncologists and/or haematologists from nine European countries (n=375) were surveyed on their last five cancer patients treated for CIA (n=1730). Information was collected on tests performed at diagnosis of anaemia, levels of haemoglobin (Hb), serum ferritin and transferrin saturation (TSAT), and applied anaemia therapies. Results – Diagnostic tests and therapies for CIA varied across Europe. Anaemia and iron status were mainly assessed by Hb (94%) and ferritin (48%) measurements. TSAT was only tested in 14%. At anaemia diagnosis, 74% of patients had Hb ≤10g/dL, including 15% with severe (Hb <8g/dL) anaemia. Low iron levels (ferritin ≤100ng/mL) were detected in 42% of evaluated patients. ESA was the most commonly used treatment (63%) and 30% of ESA‐treated patients also received iron supplementation. Most iron‐treated patients (74%) received an oral iron; intravenous iron was administered to 26%. 52% of patients received transfusions and in 76% of these, transfusions formed part of a regular anaemia treatment regimen. Management practices were similar in 2009 and 2011. Conclusion – Management of anaemia and iron status in patients treated for CIA varies substantially across Europe. Iron status is only assessed in half of the patients. In contrast to clinical evidence, iron treatment is underutilised and mainly based on oral iron supplementation. Implementation of guidelines needs to be increased, particularly the minimisation of blood transfusions. [less ▲]

Detailed reference viewed: 52 (0 ULg)